In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Snapshot: October Highlights

Executive Summary

A selection of articles you might have missed from October 2022, including discussions on inclusion in the pharmaceutical industry, cancer vaccine development and where it is taking place, and the importance of digital tools beyond care.

You may also be interested in...



Elypta Drops Data Showing Power Of Metabolite-Based MCED Test

Elypta’s MIRAM kit for multi-cancer early detection performed well in a large-scale study.

Minute Insight: Intel-Penn Tie-Up Proves Federated Approach’s Power

Federated learning has taken another step forward thanks to new research that proves it is better at spotting brain tumors. 

Snapshot: November Highlights

A selection of articles you might have missed from November 2022, during which In Vivo shone the spotlight on the Asia Pacific region.

Topics

Latest News
See All
UsernamePublicRestriction

Register

IV146754

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel